APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy

Dummer, 2015, APOL1 kidney disease risk variants: an evolving landscape, Semin Nephrol, 35, 222, 10.1016/j.semnephrol.2015.04.008 Rao, 1984, Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome, N Engl J Med, 310, 669, 10.1056/NEJM198403153101101 Genovese, 2010, Association of trypanolytic ApoL1 variants with kidney disease in African Americans, Science, 329, 841, 10.1126/science.1193032 Lipkowitz, 2013, Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans, Kidney Int, 83, 114, 10.1038/ki.2012.263 Kopp, 2011, APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy, J Am Soc Nephrol, 22, 2129, 10.1681/ASN.2011040388 Atta, 2012, HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics, Kidney Int, 82, 338, 10.1038/ki.2012.111 Kasembeli, 2015, APOL1 risk variants are strongly associated with HIV-associated nephropathy in black South Africans, J Am Soc Nephrol, 26, 2882, 10.1681/ASN.2014050469 Purswani, 2016, Brief report: APOL1 renal risk variants are associated with chronic kidney disease in children and youth with perinatal HIV infection, J Acquir Immune Defic Syndr, 73, 63, 10.1097/QAI.0000000000001010 Atta, 2016, Association of APOL1 genotype with renal histology among black HIV-positive patients undergoing kidney biopsy, Clin J Am Soc Nephrol, 11, 262, 10.2215/CJN.07490715 Barisoni, 1999, The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy, J Am Soc Nephrol, 10, 51, 10.1681/ASN.V10151 Shankland, 2014, The emergence of the glomerular parietal epithelial cell, Nat Rev Nephrol, 10, 158, 10.1038/nrneph.2014.1 Foy, 2013, Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy, Clin J Am Soc Nephrol, 8, 1524, 10.2215/CJN.10991012 Fine, 2012, APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease, J Am Soc Nephrol, 23, 343, 10.1681/ASN.2011060562 Estrella, 2015, The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status, Clin Infect Dis, 60, 646, 10.1093/cid/ciu765 Nichols, 2015, Innate immunity pathways regulate the nephropathy gene apolipoprotein L1, Kidney Int, 87, 332, 10.1038/ki.2014.270 Doyle, 2015, HIV-1 and interferons: who's interfering with whom?, Nat Rev Microbiol, 13, 403, 10.1038/nrmicro3449 Bruggeman, 2014, Plasma apolipoprotein L1 levels do not correlate with CKD, J Am Soc Nephrol, 25, 634, 10.1681/ASN.2013070700 Wakashin, 2015 Heggelund, 2004, Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication, Clin Infect Dis, 39, 264, 10.1086/421780 Hernandez, 2012, HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro, AIDS Res Hum Retroviruses, 28, 1313, 10.1089/aid.2011.0297 Nicol, 2008, Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells, J Virol, 82, 7790, 10.1128/JVI.00362-08 Ben Haij, 2015, HIV-1 tat protein induces production of proinflammatory cytokines by human dendritic cells and monocytes/macrophages through engagement of TLR4-MD2-CD14 complex and activation of NF-kappaB pathway, PLoS One, 10, e0129425, 10.1371/journal.pone.0129425 Taylor, 2014, The innate immune factor apolipoprotein L1 restricts HIV-1 infection, J Virol, 88, 592, 10.1128/JVI.02828-13 McLaren, 2015, Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses, Retrovirology, 12, 41, 10.1186/s12977-015-0165-5 Uzureau, 2016, Apolipoproteins L control cell death triggered by TLR3/TRIF signaling in dendritic cells, Eur J Immunol, 46, 1854, 10.1002/eji.201546252 Zhaorigetu, 2011, Apolipoprotein L6, induced in atherosclerotic lesions, promotes apoptosis and blocks Beclin 1-dependent autophagy in atherosclerotic cells, J Biol Chem, 286, 27389, 10.1074/jbc.M110.210245 Simard, 2002, Expression of simian immunodeficiency virus nef in immune cells of transgenic mice leads to a severe AIDS-like disease, J Virol, 76, 3981, 10.1128/JVI.76.8.3981-3995.2002 Rahim, 2009, Adult AIDS-like disease in a novel inducible human immunodeficiency virus type 1 Nef transgenic mouse model: CD4+ T-cell activation is Nef dependent and can occur in the absence of lymphophenia, J Virol, 83, 11830, 10.1128/JVI.01466-09 Zuo, 2006, HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis, J Am Soc Nephrol, 17, 2832, 10.1681/ASN.2005080878 Hiramatsu, 2007, Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model, J Am Soc Nephrol, 18, 515, 10.1681/ASN.2006030217 Chandel, 2013, HIV compromises integrity of the podocyte actin cytoskeleton through downregulation of the vitamin D receptor, Am J Physiol Renal Physiol, 304, F1347, 10.1152/ajprenal.00717.2012 Lan, 2014, APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability, Am J Physiol Renal Physiol, 307, F326, 10.1152/ajprenal.00647.2013 Mikulak, 2016, Impact of APOL1 polymorphism and IL-1beta priming in the entry and persistence of HIV-1 in human podocytes, Retrovirology, 13, 63, 10.1186/s12977-016-0296-3